FindTrial
Sign In

Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer

Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051061
Enrollment
Unknown
Registered
2021-09-11
Start date
2020-12-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

4R lymph node dissection or not:4R lymph node dissection or not

Sponsors

Tianjin Medical University Cancer Institute and Hospital;Department of Lung Cancer Surgery
Lead Sponsor

Eligibility

Sex/Gender
All
Age
23 Years to 88 Years

Inclusion criteria

Inclusion criteria: Patients were included if they had right primary NSCLC and received lobectomy or pneumonectomy with MLND.

Exclusion criteria

Exclusion criteria: 1. Had metastatic lung cancer; 2. Received pulmonary segment or pulmonary wedge resection; 3. Received LN dissection but did not meet the criteria for MLND; 4. Received preoperative neoadjuvant chemotherapy or radiotherapy; or 5. Had incomplete medical records.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Countries

China

Contacts

Public ContactChangli Wang

Tianjin Medical University Cancer Institute and Hospital

wangchangli@tjmuch.com+86 13821086868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026